Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Univercells

Univercells?uq=w9if130k
2013 FOUNDED
PRIVATE STATUS
41-50 EMPLOYEES
Series B LATEST DEAL TYPE
$18.7M LATEST DEAL AMOUNT
9 INVESTORS
Description

Provider of a novel bio-manufacturing platform designed to revolutionize biologic availability around the world. The company's platform breaks the barriers to bio-production by reinventing process architecture and manages all or part of the bio-manufacturing project, from design and building of manufacturing facilities to maintenance, enabling patients to access recombinant proteins and vaccines at affordable ways.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • Rue Auguste Piccard 48
  • 6041 Gosselies
  • Belgium

+32 02 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Univercells’s full profile, request a free trial.

Univercells Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series B) 16-Jul-2018 $18.7M 000.00 Completed Generating Revenue/Not Profitable
5. Grant 23-Jan-2018 00.000 00.000 Completed Startup
4. Early Stage VC (Series A2) 15-Dec-2017 00.000 00.000 000.00 Completed Startup
3. Grant 15-Dec-2016 000.00 00.000 Completed Startup
2. Early Stage VC (Series A) 18-Jul-2016 $3.31M $3.31M 000.00 Completed Startup
1. Accelerator/Incubator 01-Oct-2014 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Univercells Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Convertible 00,000 000.00 000.00 00 000.00 0.000
Class A 000,000 000.00 000.00 00 000.00 00.000
To view this company’s complete Cap Table, request access »

Univercells Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Global Health Investment Fund Impact Investing Minority 000 0000 000000 0
Inventures Venture Capital Minority 000 0000 000000 0
Korea Investment Partners Venture Capital Minority 000 0000 000000 0
TheClubDeal Venture Capital Minority 000 0000 000000 0
The Innovation Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Univercells Executive Team (10)

Name Title Board
Seat
Contact
Info
Hugues Bultot Co-Founder, Chief Executive Officer & Board Member
Vincent Vanderborght Chief Financial Officer
Christian Borgniet Chief Operating Officer
José Castillo Ph.D Co-Founder, Chief Technology Officer & Board Member
David Louvet Chief Human Resources Officer

2 Former Executives

You’re viewing 5 of 10 executives. Get the full list »

Univercells Board Members (7)

Name Representing Role Since Contact
Info
Doug Neugold Self Chairman 000 0000
Guillaume de Viron Self Co-Founder & Board Member 000 0000
Hugues Bultot Univercells Co-Founder, Chief Executive Officer & Board Member 000 0000
José Castillo Ph.D Univercells Co-Founder, Chief Technology Officer & Board Member 000 0000
Michael Martin Ph.D Takeda Ventures Board Observer 000 0000
You’re viewing 5 of 7 board members. Get the full list »